STAAR SurgicalvsThermo Fisher Scientific

STAA and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

STAAR Surgical (STAA) has a market value of $1.3B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, STAA moved +2.1% and TMO +19.5%. The P/E is 2,465.4 for STAA and 36.8 for TMO. Dividend yield: STAA none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    STAA$1.3B

    TMO$260B

    TMO is 199 times STAA

  • Revenue, 12 months

    STAA$328M

    TMO$47.4B

    TMO is 144 times STAA

  • Net income, 12 months

    STAA$530.0K

    TMO$7.1B

    TMO is 13,343 times STAA

  • Operating margin

    STAA0.2%

    TMO17.9%

    17.7 points apart

  • ROIC

    STAA0.2%

    TMO8.2%

    8.0 points apart

  • P/E

    STAA2,465.4

    TMO36.8

    STAA is 67 times TMO

  • Dividend yield

    STAA0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    STAA-76.7%

    TMO+11.8%

    88.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

STAA-76.7%

TMO+11.8%

5010020222023202420252026
Returns by period
PeriodSTAAWith dividendsTMOWith dividends
1 year since November 12, 2025+2.1%Price +2.1%+19.5%Price +19.1%
3 years since November 13, 2023-22.3%-8.1% a yearPrice -22.3%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-76.7%-25.3% a yearPrice -76.7%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016+151.3%+9.7% a yearPrice +151.3%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

STAASTAAR SurgicalTMOThermo Fisher Scientific

Valuation

STAATMO
Valuation
Price$26.39$700.22
Market value$1.3B$260B
Enterprise value (EV)$1.1B$295B
P/E2,465.436.8
P/E, 5-year median–32.7
P/B3.54.8
EV/EBIT1,569.534.9
Free cash flow yield1.4%2.9%

Results and growth

STAATMO
Results and growth
Revenue, 12 months$328M$47.4B
Net income, 12 months$530.0K$7.1B
Free cash flow, 12 months$18M$7.6B
Earnings per share, 12 months$0.01$18.96
Revenue growth, year on year-23.7%3.9%
Revenue growth a year, past+7.9%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

STAATMO
Margins and returns on capital
Gross margin73.6%–
Operating margin0.2%17.9%
Net margin0.2%14.9%
ROIC0.2%8.2%
ROE0.2%13.4%

Balance sheet

STAATMO
Balance sheet
Cash$206M$6.1B
Total debt$34M$41.4B
Net debt / EBITDA-22.93.7
Interest cover–5.5×

Dividends and buybacks

STAATMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield0.5%1.2%
Shareholder yield0.5%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: STAA or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, STAAR Surgical or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 199.1 times STAAR Surgical ($1.3B), at today's prices.

How did STAA and TMO stock do over the last 10 years?

Since November 15, 2016, STAA's price moved +151.3% and TMO's +371.0%. With dividends: STAA +151.3% (+9.7% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, STAA or TMO?

The dividend yield at today's price is none for STAAR Surgical and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of STAA and TMO?

At today's price, the P/E is 2,465.4 for STAA and 36.8 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, STAAR Surgical or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 0.2% for STAAR Surgical and 14.9% for Thermo Fisher Scientific, and the operating margin 0.2% and 17.9%. Revenue was $328M and $47.4B.

Which is the better investment, STAAR Surgical or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.